{"denoms":[{"counts":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"48"}],"units":"Participants"}],"groups":[{"description":"Patients receive pembrolizumab IV over 30 minutes on day 1. Cycles repeat every 21 days for up to 24 months in the absence of disease progression or unacceptable toxicity. Upon radiologic documentation of disease progression, patients may cross over to Group II.\\>\n\n\\>\\>\n\n\\>\n\n\\>\\> Laboratory Biomarker Analysis: Correlative studies\\>\n\n\\>\\>\n\n\\>\n\n\\>\\> Pembrolizumab: Given IV\\>\n\n\\>\\>\n\n\\>\n\n\\>\\> Pharmacological Study: Correlative studies","id":"BG000","title":"Phase 2 Group I (Pembrolizumab)"},{"description":"Patients receive anetumab ravtansine IV over 1 hour and pembrolizumab IV over 30 minutes on day 1. Cycles repeat every 21 days for up to 12 months for anetumab ravtansine and up to 24 months for pembrolizumab in the absence of disease progression or unacceptable toxicity.\\> \\>\\>\n\n\\>\n\n\\>\\> Anetumab Ravtansine: Given IV\\>\n\n\\>\\>\n\n\\>\n\n\\>\\> Laboratory Biomarker Analysis: Correlative studies\\>\n\n\\>\\>\n\n\\>\n\n\\>\\> Pembrolizumab: Given IV\\>\n\n\\>\\>\n\n\\>\n\n\\>\\> Pharmacological Study: Correlative studies","id":"BG001","title":"Phase 2 Group II (Anetumab Ravtansine, Pembrolizumab)"},{"description":"Anetumab ravtansine: Day 1 of each cycle for up to 12 months\\> MK-3475 (pembrolizumab): Day 1 of each cycle for up to 24 months","id":"BG002","title":"Phase 1 Cohort DLT 1: Anetumab Ravtansine & MK-3475"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"46.0","upperLimit":"85.0","value":"70.0"},{"groupId":"BG001","lowerLimit":"23.0","upperLimit":"88.0","value":"67.5"},{"groupId":"BG002","lowerLimit":"48","upperLimit":"81","value":"72"},{"groupId":"BG003","lowerLimit":"23.0","upperLimit":"88.0","value":"68.0"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"16"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"32"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"38"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"8"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"4"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"41"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"3"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}]}],"title":"Borderline malignancy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"25"}]}],"title":"Grade cannot be assessed"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"3"}]}],"title":"Poorly Differentiated"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}]}],"title":"Well Differentiated"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"18"}]}],"title":"Missing"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Histologic Grade","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"}]}],"title":"Stage IA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"3"}]}],"title":"Stage IB"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"}]}],"title":"Stage II"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"3"}]}],"title":"Stage III"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"6"}]}],"title":"Stage IIIB"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"22"}]}],"title":"Stage IV"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"10"}]}],"title":"Missing"}],"description":"IA: Stage grouping (T1, N0, M0) or (T2, N0, M0)\\> IB: Stage grouping (T3, N0, M0)\\> II: Stage grouping (T1 or T2, N1, M0)\\> IIIA: Stage grouping (T3, N1, M0)\\> IIIB: Stage grouping (T1-T3, N2, M0) or (T4, Any N, M0)\\> IV: Stage grouping (Any T, Any N, M1)","paramType":"COUNT_OF_PARTICIPANTS","title":"Disease Stage","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"48.8","upperLimit":"100.2","value":"77.2"},{"groupId":"BG001","lowerLimit":"53.2","upperLimit":"108.0","value":"80.1"},{"groupId":"BG002","lowerLimit":"51.8","upperLimit":"173","value":"85.0"},{"groupId":"BG003","lowerLimit":"48.8","upperLimit":"173","value":"80.4"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Weight","unitOfMeasure":"kg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"152.8","upperLimit":"188.0","value":"168.4"},{"groupId":"BG001","lowerLimit":"152.0","upperLimit":"188.0","value":"173.1"},{"groupId":"BG002","lowerLimit":"90.9","upperLimit":"196","value":"167.3"},{"groupId":"BG003","lowerLimit":"90.9","upperLimit":"196","value":"169.2"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Height","unitOfMeasure":"cm"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"1.4","upperLimit":"2.3","value":"1.9"},{"groupId":"BG001","lowerLimit":"1.6","upperLimit":"2.3","value":"1.9"},{"groupId":"BG002","lowerLimit":"1.5","upperLimit":"2.6","value":"1.9"},{"groupId":"BG003","lowerLimit":"1.4","upperLimit":"2.6","value":"1.9"}]}]}],"description":"Body Surface Area","dispersionType":"FULL_RANGE","paramType":"MEAN","title":"BSA","unitOfMeasure":"m^2"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"10"}]}],"title":"0"},{"categories":[{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"38"}]}],"title":"1"}],"description":"Eastern Cooperative Oncology Group (ECOG) performance status.\\> ECOG = 0: Fully active, able to carry on all pre-disease performance without restriction. \\> ECOG = 1: Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work. \\> ECOG = 2: Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours. \\> ECOG = 0 is better. ECOG = 2 is worse.","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG Performance Score","unitOfMeasure":"Participants"}]}